相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Loss of histone H3K27me3 identifies a subset of meningiomas with increased risk of recurrence
Leah M. Katz et al.
ACTA NEUROPATHOLOGICA (2018)
DNA methylation-based classification of central nervous system tumours
David Capper et al.
NATURE (2018)
Immunohistochemical analysis of H3K27me3 demonstrates global reduction in group-A childhood posterior fossa ependymoma and is a powerful predictor of outcome
Pooja Panwalkar et al.
ACTA NEUROPATHOLOGICA (2017)
The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
David N. Louis et al.
ACTA NEUROPATHOLOGICA (2016)
Lowered H3K27me3 and DNA hypomethylation define poorly prognostic pediatric posterior fossa ependymomas
Jill Bayliss et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
ATRX immunostaining predicts IDH and H3F3A status in gliomas
Azadeh Ebrahimi et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2016)
Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas
Daniel J. Brat et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
ATRX and IDH1-R132H immunohistochemistry with subsequent copy number analysis and IDH sequencing as a basis for an integrated diagnostic approach for adult astrocytoma, oligodendroglioma and glioblastoma
David E. Reuss et al.
ACTA NEUROPATHOLOGICA (2015)
Upregulating mutations in the TERT promoter commonly occur in adult malignant gliomas and are strongly associated with total 1p19q loss
Hideyuki Arita et al.
ACTA NEUROPATHOLOGICA (2013)
Distribution of TERT promoter mutations in pediatric and adult tumors of the nervous system
Christian Koelsche et al.
ACTA NEUROPATHOLOGICA (2013)
The alternative lengthening of telomere phenotype is significantly associated with loss of ATRX expression in high-grade pediatric and adult astrocytomas: a multi-institutional study of 214 astrocytomas
Malak Abedalthagafi et al.
MODERN PATHOLOGY (2013)
Frequent ATRX mutations and loss of expression in adult diffuse astrocytic tumors carrying IDH1/IDH2 and TP53 mutations
Xiao-Yang Liu et al.
ACTA NEUROPATHOLOGICA (2012)
IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype
Sevin Turcan et al.
NATURE (2012)
Frequent ATRX, CIC, FUBP1 and IDH1 mutations refine the classification of malignant gliomas
Yuchen Jiao et al.
ONCOTARGET (2012)
Loss of ATRX, Genome Instability, and an Altered DNA Damage Response Are Hallmarks of the Alternative Lengthening of Telomeres Pathway
Courtney A. Lovejoy et al.
PLOS GENETICS (2012)
The Polycomb complex PRC2 and its mark in life
Raphael Margueron et al.
NATURE (2011)
Drosophila enhancer of Zeste/ESC complexes have a histone H3 methyltransferase activity that marks chromosomal polycomb sites
B Czermin et al.
CELL (2002)
Histone methyltransferase activity of a Drosophila polycomb group repressor complex
J Müller et al.
CELL (2002)